In June 2023, the Treasury Department and the IRS issued long-awaited proposed regulations addressing transfers of green energy tax credits under the Inflation Reduction Act (IRA). 

Prior to the IRA, a REIT typically held solar

Continue Reading IRS provides favorable guidance on REIT tax treatment of transferable renewable energy credits for rooftop solar panels and electric vehicle charging stations

Against the backdrop of evolving state regulatory landscapes for controlled substances, including psychedelics for therapeutic uses, the US Food and Drug Administration (FDA) recently released a draft guidance entitled Psychedelic Drugs: Considerations for Clinical Investigations

Continue Reading FDA issues draft guidance for clinical investigations of psychedelic drugs

As companies consider the benefits of using generative artificial intelligence, they must also balance such benefits against certain legal and business risks.

This article explores possible frameworks for a policy that strategically leverages the benefits

Continue Reading Generative AI – framing a business-centric policy to address opportunities and risks

FDA regulates prescription drug advertising under the authority of the Federal Food, Drug, and Cosmetic Act (FDCA) and the implementing regulations. In 2018, after observing an increase in quantitative presentations of efficacy and risk information

Continue Reading Key updates from FDA’s latest guidance on presenting efficacy and risk data in DTC promotion